robot handshake human background futuristic digital age2 1
female doctor wearing mask writing clipboard laboratory2 1
scientist conducting gel electrophoresis biological process as part research2
line 12 1

Welcome to EUSTM-2023 Congress

The European Society for Translational Medicine cordially invites you to attend the 10th Annual Congress of the European Society for Translational Medicine (EUSTM-2023 Congress on Diagnostics, AI & ML) which will be held in virtual format during 6-8 October 2023.

The Congress will focus on recent advances in the field of novel screening & diagnostics methods, tools, techniques & biomarkers covering immuno-oncology & multi-omics oncology, infectious diseases, point-of-care diagnostics and single-cell multiomics & systems biology.

In addition, the congress will focus on latest advancements in Artificial intelligence & Machine Learning (AI & ML) fields including applications and role in general medicine, diagnostics, therapeutics and drug discovery, development and repositioning.

The Congress not only provides a unique platform for scientific exchange and discussion about the recent progress in both bench and bed sides, but also an avenue for global networking with key stakeholders in academic research, clinical care giver, public health workers, and industrial leaders.

We look forward to welcome you.


Congress Co-Chairs


Quickly extend client-centric sources with unique.


Quickly extend client-centric sources with unique.

Congress Theme A
Novel Screening & Diagnostics Methods, Tools, Techniques & Biomarkers

  • Analytical and synthetic methodologies
  • Validation of Biomarkers
  • Translation for Diagnostic Use
  • Medical Laboratory equipment
  • Diagnostic medical Equipment
  • Tissue based technologies (MUSE)
  • Cell based technologies (MorphoGo and Deep cell)
  • Liquid biopsy and fluid-based diagnostics
  • Spatial assays for translational research
  • Integrative analysis of expression and tissue data
  • Multiplexed imaging and spatial transcriptomics
  • Spatially resolved proteomics
  • Genomic and molecular Oncology testing
  • Minimal residual disease detection
  • Biomarkers for Immunotherapy
  • Cell-Free DNA in Clinical Oncology
  • Gene Mutations in Patients
  • Cancer metabolomics and biomarkers
  • Oncology companion diagnostics
  • Predictive biomarkers
  • prognostic cancer biomarkers
  • Multi-cancer early detection

  • Innovation in at-home testing and self-testing
  • Advances in mobile and digital technologies for point-of-care diagnostics
  • CRISPR and synthetic biology for next-generation POCT
  • Digital and connected diagnostics for remote monitoring
  • Lab-on-Chip
  • Rapid infectious disease diagnostics and community surveillance
  • SARS-CoV-2 sequencing and variant detection
  • Multiplex respiratory virus testing
  • Host response vs. pathogen detection
  • Metagenomics-based diagnostics
  • Molecular diagnostics in resource-limited settings
  • NGS advances in clinical diagnostics
  • Single-cell transcriptomics and single-cell genomics
  • Development of computational tools
  • Advances in spatial transcriptomics
  • Single-cell epigenome profiling
  • Single-cell proteomics and metabolomics
  • Systems biology and single-cell analysis
  • Single-cell immune profiling
Congress Theme B
Artificial Intelligence & Machine Learning
(AI & ML)
  • Lab med (chemistry, toxicology, micro, serology)
  • Anatomic pathology (cytology, tissue based surgical pathology)
  • Liquid biopsy
  • Radiology
  • Oncology – solid tumour
  • Oncology – blood malignancies
  • Cardiovascular diseases
  • Infectious diseases
  • Other diseases